Praxis Launches a Patient Recruitment Campaign for An Infant Vaccine for Bacterial Meningitis

Brentwood, TN -- Jan. 6, 2006 -- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a major pharmaceutical company for a medical research study taking place in about 80 cities across the United States. The recruitment period will last six months and will aid sites in enrolling 3,000 infants age 6-12 weeks of age. The purpose of this Phase III study is to determine if an investigational vaccine is safe and effective in protecting infants against an additional bacteria that causes serious infections, such as meningitis.

Praxis is providing a variety of patient recruitment services for this clinical research study, including study branding, patient education materials, website development, outreach to local clinics and health department, and public relations initiatives to reach parents of infants. Materials will be developed in both English and Spanish.

“This is a great opportunity to apply our pediatric experience in the area of biologics,” said David Fox, president and CEO of Praxis. “Obviously, vaccine research continues to be an important area of research to protect children and adults from a variety of diseases, and we are happy to play a role in that.”

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Releases